Information Provided By:
Fly News Breaks for September 2, 2015
WMGI
Sep 2, 2015 | 06:07 EDT
Piper Jaffray analyst Matt O'Brien calls news of Wright Medical's regulatory clearance for Augment surprising and "clearly a positive." Most had expected approval to be delayed until the end of 2015, the analyst tells investors in a research note. Nonetheless, O'Brien sees little upside to his price target of $27 and keeps a Neutral rating on Wright. He expects the stock to rally about 10% today on last night's news.
News For WMGI From the Last 2 Days
There are no results for your query WMGI